Heather Raymon

Heather Raymon

Corporate Officer/Principal at ARTIVA BIOTHERAPEUTICS, INC.

Net worth: 1 M $ as of 29/06/2026

61 year
Health Technology
Consumer Services

Profile

Heather Raymon is currently Senior VP-Research & Early Development at Artiva Biotherapeutics, Inc. since 2023.
Former positions include Executive Director-Early Development Program at Bristol Myers Squibb Co. and Senior Director & Head-Pharmacology at Celgene Corp.
Education includes an undergraduate degree from State University of New York at Albany and a doctorate from the University of California, Irvine.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
18/05/2026 148,228 ( 0.31% ) 1 M $ 29/06/2026

Heather Raymon active positions

CompaniesPositionStart
ARTIVA BIOTHERAPEUTICS, INC. Corporate Officer/Principal 30/09/2020

Former positions of Heather Raymon

CompaniesPositionEnd
CELGENE Corporate Officer/Principal -
BRISTOL-MYERS SQUIBB COMPANY Corporate Officer/Principal -
See the detail of Heather Raymon's experience

Training of Heather Raymon

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

4

1st degree connections

5

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies5

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

  1. Stock Market
  2. Insiders
  3. Heather Raymon